ArticleBMJ open2025

Faecal microbiota transplantation combined with platinum-based doublet chemotherapy and tislelizumab as first-line treatment for driver-gene negative advanced non-small cell lung cancer (NSCLC): study protocol for a prospective, multicentre, single-arm exploratory trial.

Yanshuang Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.